Upregulation of programmed cell death ligand 1 promotes resistance response in non‐small‐cell lung cancer patients treated with neo‐adjuvant chemotherapy

To assess the association of the programmed cell death ligand 1 (PD‐L1) with cisplatin‐based neo‐adjuvant chemotherapy (NAC) response, we investigated the level of PD‐L1 and found increased PD‐L1 expression in chemo‐resistant tumors compared with chemo‐sensitive tumors according to RNA‐Seq analysis....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Panpan, Ma, Yuanyuan, Lv, Chao, Huang, Miao, Li, Mingzhen, Dong, Bin, Liu, Xijuan, An, Guo, Zhang, Wenlong, Zhang, Jianzhi, Zhang, Liyi, Zhang, Shanyuan, Yang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132280/
https://www.ncbi.nlm.nih.gov/pubmed/27581532
http://dx.doi.org/10.1111/cas.13072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132280/
https://www.ncbi.nlm.nih.gov/pubmed/27581532
http://dx.doi.org/10.1111/cas.13072

Ejemplares similares